These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32383983)

  • 1. Chondroitin polymerizing factor (CHPF) contributes to malignant proliferation and migration of hepatocellular carcinoma cells.
    Xu Q; Lin W; Tao C; Huang X; Li J
    Biochem Cell Biol; 2020 Jun; 98(3):362-369. PubMed ID: 32383983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHPF promotes gastric cancer tumorigenesis through the activation of E2F1.
    Lin X; Han T; Xia Q; Cui J; Zhuo M; Liang Y; Su W; Wang L; Wang L; Liu Z; Xiao X
    Cell Death Dis; 2021 Sep; 12(10):876. PubMed ID: 34564711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chondroitin polymerizing factor promotes breast carcinoma cell proliferation, invasion and migration and affects expression of epithelial-mesenchymal transition-related markers.
    Li Y; Gong H; Feng L; Mao D; Xiao Y; Wang Y; Huang L
    FEBS Open Bio; 2021 Feb; 11(2):423-434. PubMed ID: 33301643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CHPF modulates cell proliferation and invasion in lung cancer.
    Cao C; Liu Y; Wang Q; Zhao J; Shi M; Zheng J
    Braz J Med Biol Res; 2020; 53(5):e9021. PubMed ID: 32348423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SWELL1 promotes cell growth and metastasis of hepatocellular carcinoma in vitro and in vivo.
    Lu P; Ding Q; Li X; Ji X; Li L; Fan Y; Xia Y; Tian D; Liu M
    EBioMedicine; 2019 Oct; 48():100-116. PubMed ID: 31597595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondroitin polymerizing factor (CHPF) promotes development of malignant melanoma through regulation of CDK1.
    Sun W; Zhao F; Xu Y; Huang K; Guo X; Zheng B; Liu X; Luo Z; Kong Y; Xu M; Schadendorf D; Chen Y
    Cell Death Dis; 2020 Jul; 11(7):496. PubMed ID: 32612115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
    Li Y; Bai W; Zhang J
    Biomed Pharmacother; 2017 Aug; 92():1038-1044. PubMed ID: 28609841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of chondroitin polymerizing factor (CHPF) as tumor promotor in cholangiocarcinoma through regulating cell proliferation, cell apoptosis and cell migration.
    Duan X; Yang J; Jiang B; Duan W; Wei R; Zhang H; Mao X
    Cell Cycle; 2021; 20(5-6):591-602. PubMed ID: 33651657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway.
    Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S
    J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased long noncoding RNA LINC00511 is correlated with poor prognosis and contributes to cell proliferation and metastasis by modulating miR-424 in hepatocellular carcinoma.
    Wang RP; Jiang J; Jiang T; Wang Y; Chen LX
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3291-3301. PubMed ID: 31081082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.
    Wang H; Ke J; Guo Q; Barnabo Nampoukime KP; Yang P; Ma K
    J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. circZFR promotes cell proliferation and migration by regulating miR-511/AKT1 axis in hepatocellular carcinoma.
    Yang X; Liu L; Zou H; Zheng YW; Wang KP
    Dig Liver Dis; 2019 Oct; 51(10):1446-1455. PubMed ID: 31147216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
    Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
    Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin Y Modulates the Proliferation, Invasion, and Metastasis of Hepatocellular Carcinoma Cells.
    Shi K; Ru Q; Zhang C; Huang J
    Med Sci Monit; 2018 Mar; 24():1642-1653. PubMed ID: 29557391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAK1 promotes proliferation, migration and invasion of hepatocellular carcinoma by facilitating EMT via directly up-regulating Snail.
    Cao F; Yin LX
    Genomics; 2020 Jan; 112(1):694-702. PubMed ID: 31071459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B).
    Hu J; Duan B; Jiang W; Fu S; Gao H; Lu L
    Cancer Med; 2019 Jun; 8(6):3152-3166. PubMed ID: 30972979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.